HUDSON, N.Y., May 31 (Bernama-GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a license agreement with ERS Genomics ("ERS") to utilize the company's CRISPR-Cas9 technology to generate unique murine models.
Under the agreement, Taconic receives a worldwide non-exclusive license to the CRISPR-Cas9 patents often referred to as the "UC Berkeley patent." ERS Genomics founder, Emmanuelle Charpentier, is a co-inventor of the CRISPR-Cas9 technology. This agreement with ERS complements Taconic's CRISPR service platform, adding to its existing license with the Broad Institute. Holding licenses with both groups provides Taconic access for use in all cell types as well as for use in both mouse and rat species, a rare distinction within the animal model field.
Under the agreement, Taconic receives a worldwide non-exclusive license to the CRISPR-Cas9 patents often referred to as the "UC Berkeley patent." ERS Genomics founder, Emmanuelle Charpentier, is a co-inventor of the CRISPR-Cas9 technology. This agreement with ERS complements Taconic's CRISPR service platform, adding to its existing license with the Broad Institute. Holding licenses with both groups provides Taconic access for use in all cell types as well as for use in both mouse and rat species, a rare distinction within the animal model field.
No comments:
Post a Comment